GB1072414A - New dihydrothieno(3,2-d)pyrimidines - Google Patents

New dihydrothieno(3,2-d)pyrimidines

Info

Publication number
GB1072414A
GB1072414A GB2509464A GB2509464A GB1072414A GB 1072414 A GB1072414 A GB 1072414A GB 2509464 A GB2509464 A GB 2509464A GB 2509464 A GB2509464 A GB 2509464A GB 1072414 A GB1072414 A GB 1072414A
Authority
GB
United Kingdom
Prior art keywords
group
alkyl
formula
free
halogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2509464A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US288491A external-priority patent/US3272811A/en
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of GB1072414A publication Critical patent/GB1072414A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises compounds of the Formula I wherein R represents an unsubstituted amino group; R1 represents a hydroxy group substituted by a (C1- 5 alkoxy)-C1- 5 alkyl group, an alkylmercapto group, an unsubstituted amino group or an alkyl, alkenyl, formula -NR3R4 (in which R3 represents an unsubstituted amino group or an alkyl, alkenyl, hydroxyalkyl, alkoxyalkyl or a dialkylaminoalkyl group of not more than 10 carbon atoms or an aralkyl or cycloalkyl group and R4 represents a hydrogen atom or an alkyl or hydroxyalkyl group of not more than 10 carbon atoms or R3 and R4 together with the adjacent nitrogen atom represent a heterocyclic group which may contain a further hetero atom and which may be substituted by a C1- 3 alkyl group); R2 represents a methyl group and n represents 0 or 1, and non-toxic acid addition salts thereof, and the preparation thereof by reacting a compound of the Formula II, wherein one of A and A1 represents a halogen atom or a free or C1- 5 alkyl substituted mercapto group and the other (if not representing a halogen atom or a free or C1- 5 alkyl substituted mercapto group) represents any of the groups which may be represented by R and R1 respectively, with a compound of the formula RH (where A represents a halogen atom or a free or C1- 5 alkyl substituted mercapto group) and/or R1H (where A1 represents a halogen atom or a free or C1- 5 alkyl substituted mercapto group), and, if desired, converting the product into a non-toxic acid addition salt thereof. <FORM:1072414/C2/1> 2 - Chloro - 4 - morpholino - dihydrothieno-[3,2-d]pyrimidin may be prepared by the action of morpholine on 2,4-dichloro-dihydrothieno[3,2-d]pyrimidine. Therapeutic compositions, which have cardiovascular, sedative, diuretic, cytostatic, bacteriostatic, antiphlogistic and/or anti-pyretic activities, and which may take the forms of capsules, dragees, powders, drop solutions, suspensions, solutions, ampoules and suppositories, for oral, parenteral and topical application, comprise compounds of the Formula I or their non-toxic acid addition salts together with a pharmaceutical carrier.
GB2509464A 1963-06-17 1964-06-17 New dihydrothieno(3,2-d)pyrimidines Expired GB1072414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US288491A US3272811A (en) 1962-07-04 1963-06-17 Dihydrothieno-[3, 4-d]-pyrimidines

Publications (1)

Publication Number Publication Date
GB1072414A true GB1072414A (en) 1967-06-14

Family

ID=23107339

Family Applications (2)

Application Number Title Priority Date Filing Date
GB2509364A Expired GB1072413A (en) 1963-06-17 1964-06-17 New dihydrothieno[3,2-d]pyrimidines
GB2509464A Expired GB1072414A (en) 1963-06-17 1964-06-17 New dihydrothieno(3,2-d)pyrimidines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB2509364A Expired GB1072413A (en) 1963-06-17 1964-06-17 New dihydrothieno[3,2-d]pyrimidines

Country Status (7)

Country Link
BE (2) BE649347A (en)
CH (2) CH442328A (en)
ES (1) ES301103A1 (en)
FR (4) FR1555460A (en)
GB (2) GB1072413A (en)
NL (4) NL6406834A (en)
SE (2) SE300214B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI380984B (en) * 2006-04-19 2013-01-01 Boehringer Ingelheim Int Novel compounds for the treatment of inflammatory diseases
US8604039B2 (en) 2006-04-19 2013-12-10 Boehringer Ingelheim International Gmbh Dihydrothienopyrimidines for the treatment of inflammatory diseases
US8637519B2 (en) 2007-10-19 2014-01-28 Boehringer Ingelheim International Gmbh Heterocycle-substituted piperazino-dihydrothienopyrimidines
US8754073B2 (en) 2007-10-19 2014-06-17 Boehringer Ingelheim International Gmbh Substituted piperazino-dihydrothienopyrimidines
US9090626B2 (en) 2007-10-19 2015-07-28 Boehringer Ingelheim International Gmbh Piperazino-dihydrothienopyrimidine derivatives
US9150586B2 (en) 2011-08-24 2015-10-06 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0276057B1 (en) * 1987-01-21 1994-03-09 Merck & Co. Inc. Piperazinylpyrimidines as beta-adrenergic receptor blocking agents

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8354531B2 (en) 2005-04-21 2013-01-15 Boehringer Ingelheim International Gmbh Compounds for the treatment of inflammatory diseases
TWI380984B (en) * 2006-04-19 2013-01-01 Boehringer Ingelheim Int Novel compounds for the treatment of inflammatory diseases
US8604039B2 (en) 2006-04-19 2013-12-10 Boehringer Ingelheim International Gmbh Dihydrothienopyrimidines for the treatment of inflammatory diseases
US8637519B2 (en) 2007-10-19 2014-01-28 Boehringer Ingelheim International Gmbh Heterocycle-substituted piperazino-dihydrothienopyrimidines
US8754073B2 (en) 2007-10-19 2014-06-17 Boehringer Ingelheim International Gmbh Substituted piperazino-dihydrothienopyrimidines
US9090626B2 (en) 2007-10-19 2015-07-28 Boehringer Ingelheim International Gmbh Piperazino-dihydrothienopyrimidine derivatives
US9115142B2 (en) 2007-10-19 2015-08-25 Boehringer Ingelheim International Gmbh Heterocycle-substituted piperazino-dihydrothienopyrimidines
US9150586B2 (en) 2011-08-24 2015-10-06 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US10745411B2 (en) 2011-08-24 2020-08-18 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma

Also Published As

Publication number Publication date
BE649348A (en) 1964-12-16
NL124131C (en)
FR3824M (en) 1966-01-10
SE300213B (en) 1968-04-22
FR1555460A (en) 1969-01-31
NL6406835A (en) 1964-12-18
CH446358A (en) 1967-11-15
ES301103A1 (en) 1965-01-16
FR3648M (en) 1965-10-25
NL122810C (en)
FR1555459A (en) 1969-01-31
NL6406834A (en) 1964-12-18
BE649347A (en) 1964-12-16
CH442328A (en) 1967-08-31
GB1072413A (en) 1967-06-14
SE300214B (en) 1968-04-22

Similar Documents

Publication Publication Date Title
GB1057612A (en) Thieno-pyrimidines
ES336869A1 (en) 3,4-cis-4-aryl-isoflavanes
GB1072414A (en) New dihydrothieno(3,2-d)pyrimidines
GB1131191A (en) New imidazole derivatives, their preparation and use
GB1028405A (en) New tetrahydro-pyrido-[4,3-d]-pyrimidines and processes for their preparation
ES362543A1 (en) 3-hydroxy and 3-mercapto-pyrazinoyl-guanidines,corresponding ethers and thioethers and processes for their preparation
DE3169480D1 (en) Trisubstituted pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them
GB1213172A (en) Dibenzothiazepine derivatives and production of the same
GB1065317A (en) Dihydrothiopyrano-[4,3-d]-pyrimidines and their preparation
GB1033383A (en) New tetrahydro-pyrido-[4,3-d]-pyrimidines
ES8200887A1 (en) 2-(Perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them.
SE321467B (en)
IE36867L (en) Potentiated antimicrobial compositions
GB1101179A (en) Improvements in or relating to nitrofuryl quinazolines
GB1075188A (en) Dithiinopyrimidines
GB1318901A (en) Alpha-aminoalkylbenzyl alcohols
GB1268469A (en) Halomethylquinolylamino-benzamides
GB1093187A (en) Dibenzothiadiazepine dioxide derivatives
GB938042A (en) Phenoxyalkanes
GB1088102A (en) Halogen substituted pyrido-pyrimidines
GB1040542A (en) New guanidine derivatives and process for preparing the same
GB850431A (en) Improvements in or relating to phenthiazine derivatives
GB959699A (en) New pyrimidine derivatives
GB1178930A (en) Pharmaceutical Compositions
GB926696A (en) Pyrimidine derivatives